We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: A case‐control study.
- Authors
Fadini, Gian Paolo; Morieri, Mario Luca; Longato, Enrico; Bonora, Benedetta Maria; Pinelli, Silvia; Selmin, Elisa; Voltan, Giacomo; Falaguasta, Daniele; Tresso, Silvia; Costantini, Giorgia; Sparacino, Giovanni; Di Camillo, Barbara; Tramontan, Lara; Cattelan, Anna Maria; Vianello, Andrea; Fioretto, Paola; Vettor, Roberto; Avogaro, Angelo
- Abstract
Because other coronaviruses enter the cells by binding to dipeptidyl‐peptidase‐4 (DPP‐4), it has been speculated that DPP‐4 inhibitors (DPP‐4is) may exert an activity against severe acute respiratory syndrome coronavirus 2. In the absence of clinical trial results, we analysed epidemiological data to support or discard such a hypothesis. We retrieved information on exposure to DPP‐4is among patients with type 2 diabetes (T2D) hospitalized for COVID‐19 at an outbreak hospital in Italy. As a reference, we retrieved information on exposure to DPP‐4is among matched patients with T2D in the same region. Of 403 hospitalized COVID‐19 patients, 85 had T2D. The rate of exposure to DPP‐4is was similar between T2D patients with COVID‐19 (10.6%) and 14 857 matched patients in the region (8.8%), or 793 matched patients in the local outpatient clinic (15.4%), 8284 matched patients hospitalized for other reasons (8.5%), and when comparing 71 patients hospitalized for COVID‐19 pneumonia (11.3%) with 351 matched patients with pneumonia of another aetiology (10.3%). T2D patients with COVID‐19 who were on DPP‐4is had a similar disease outcome as those who were not. In summary, we found no evidence that DPP‐4is might affect hospitalization for COVID‐19.
- Subjects
ITALY; COVID-19; TYPE 2 diabetes; COVID-19 pandemic; CASE-control method
- Publication
Diabetes, Obesity & Metabolism, 2020, Vol 22, Issue 10, p1946
- ISSN
1462-8902
- Publication type
Article
- DOI
10.1111/dom.14097